Germany Immuno Chemistry Market Outlook to 2024

Published : Nov-2017

No. of Pages : 144

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Immuno Chemistry Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 9
3 Immuno Chemistry Market, Germany 13
3.1 Immuno Chemistry Market, Germany, Revenue ($m), 2010-2017 13
3.2 Immuno Chemistry Market, Germany, Revenue ($m), 2017-2024 15
3.2.1 Complement Deficiency Tests Market, Germany, Revenue ($m), by Segment, 2010-2017 17
3.2.2 Diabetes Assays Market, Germany, Revenue ($m), by Segment, 2010-2017 19
3.2.3 Disease Specific Immunochemistry Market, Germany, Revenue ($m), by Segment, 2010-2017 21
3.2.4 Endocrinology Tests Market, Germany, Revenue ($m), by Segment, 2010-2017 23
3.2.5 IgE Allergy Blood Tests Market, Germany, Revenue ($m), by Segment, 2010-2017 25
3.2.6 Immunochemistry Analyzers Market, Germany, Revenue ($m), by Segment, 2010-2017 27
3.2.7 Immunochemistry Rapid Tests & POC Market, Germany, Revenue ($m), by Segment, 2010-2017 29
3.2.8 Vitamins Tests Market, Germany, Revenue ($m), by Segment, 2010-2017 31
3.2.9 Complement Deficiency Tests Market, Germany, Revenue ($m), by Segment, 2017-2024 33
3.2.10 Diabetes Assays Market, Germany, Revenue ($m), by Segment, 2017-2024 35
3.2.11 Disease Specific Immunochemistry Market, Germany, Revenue ($m), by Segment, 2017-2024 37
3.2.12 Endocrinology Tests Market, Germany, Revenue ($m), by Segment, 2017-2024 39
3.2.13 IgE Allergy Blood Tests Market, Germany, Revenue ($m), by Segment, 2017-2024 41
3.2.14 Immunochemistry Analyzers Market, Germany, Revenue ($m), by Segment, 2017-2024 43
3.2.15 Immunochemistry Rapid Tests & POC Market, Germany, Revenue ($m), by Segment, 2017-2024 45
3.2.16 Vitamins Tests Market, Germany, Revenue ($m), by Segment, 2017-2024 47
3.3 Immuno Chemistry Market, Germany, Volume (Units), 2010-2017 49
3.4 Immuno Chemistry Market, Germany, Volume (Units), 2017-2024 51
3.4.1 Complement Deficiency Tests Market, Germany, Volume (Units), by Segment, 2010-2017 53
3.4.2 Diabetes Assays Market, Germany, Volume (Units), by Segment, 2010-2017 55
3.4.3 Disease Specific Immunochemistry Market, Germany, Volume (Units), by Segment, 2010-2017 57
3.4.4 Endocrinology Tests Market, Germany, Volume (Units), by Segment, 2010-2017 59
3.4.5 IgE Allergy Blood Tests Market, Germany, Volume (Units), by Segment, 2010-2017 61
3.4.6 Immunochemistry Analyzers Market, Germany, Volume (Units), by Segment, 2010-2017 63
3.4.7 Immunochemistry Rapid Tests & POC Market, Germany, Volume (Units), by Segment, 2010-2017 65
3.4.8 Vitamins Tests Market, Germany, Volume (Units), by Segment, 2010-2017 67
3.4.9 Complement Deficiency Tests Market, Germany, Volume (Units), by Segment, 2017-2024 69
3.4.10 Diabetes Assays Market, Germany, Volume (Units), by Segment, 2017-2024 71
3.4.11 Disease Specific Immunochemistry Market, Germany, Volume (Units), by Segment, 2017-2024 73
3.4.12 Endocrinology Tests Market, Germany, Volume (Units), by Segment, 2017-2024 75
3.4.13 IgE Allergy Blood Tests Market, Germany, Volume (Units), by Segment, 2017-2024 77
3.4.14 Immunochemistry Analyzers Market, Germany, Volume (Units), by Segment, 2017-2024 79
3.4.15 Immunochemistry Rapid Tests & POC Market, Germany, Volume (Units), by Segment, 2017-2024 81
3.4.16 Vitamins Tests Market, Germany, Volume (Units), by Segment, 2017-2024 83
3.5 Immuno Chemistry Market, Germany, Average Price ($), 2010-2024 85
3.6 Immuno Chemistry Market, Germany, Distribution Share by Revenue ($m), 2017 89
3.7 Immuno Chemistry Market, Germany, Company Share by Revenue ($m), 2017 90
4 Overview of Key Companies in Germany, Immuno Chemistry Market 92
4.1 F. Hoffmann-La Roche Ltd 92
4.1.1 Company Overview 92
4.2 Siemens Healthcare GmbH 92
4.2.1 Company Overview 92
4.3 Abbott Laboratories 92
4.3.1 Company Overview 92
4.4 Beckman Coulter Inc 92
4.4.1 Company Overview 92
4.5 Thermo Fisher Scientific Inc 93
4.5.1 Company Overview 93
4.6 bioMerieux SA 93
4.6.1 Company Overview 93
4.7 Bio-Rad Laboratories Inc 93
4.7.1 Company Overview 93
4.8 DiaSorin S.p.A 93
4.8.1 Company Overview 93
4.9 Diagnostic Automation/ Cortez Diagnostics Inc 94
4.9.1 Company Overview 94
5 Immuno Chemistry Market Pipeline Products 95
6 Financial Deals Landscape 98
6.1 Acquisition 98
6.1.1 DIAsource ImmunoAssays Acquires Viro-Immun Diagnostics 98
6.1.2 Cathay Fortune International to Acquire Epigenomics 99
6.2 Asset Transactions 101
6.2.1 DiaSorin to Acquire ELISA Immunodiagnostic Business Portfolio from Siemens Healthcare for USD55.3 Million 101
6.3 Debt Offerings 103
6.3.1 Epigenomics Raises USD8.5 Million in Private Placement of Bonds 103
6.3.2 Fresenius Raises USD742.5 Million in Private Placement of 0.875% Notes Due 2022 104
6.3.3 Fresenius Raises USD742.5 Million in Private Placement of 1.5% Notes Due 2024 105
6.3.4 Fresenius Raises USD742.5 Million in Private Placement of 2.125% Notes Due 2027 106
6.3.5 Fresenius Raises USD530.4 Million in Private Placement of 3% Notes Due 2032 107
6.4 Equity Offerings 108
6.4.1 Epigenomics Raises USD6.5 Million in Private Placement of Shares 108
6.4.2 Siemens Healthcare May Raise up to USD47.3 Billion in IPO 109
6.4.3 Siemens Healthcare Plans IPO of Shares 110
6.5 Partnerships 111
6.5.1 Singulex Enters into Agreement with Qiagen 111
7 Recent Developments 112
7.1 Corporate Communications 112
7.1.1 Aug 16, 2017: Curetis Announces Management Board Changes 112
7.1.2 Jul 21, 2017: Fresenius appoints Rachel Empey as Chief Financial Officer 112
7.1.3 May 31, 2017: apceth Biopharma appoints Dusan Kosijer as Chief Financial Officer 112
7.1.4 Apr 12, 2017: Curetis Expands Supervisory and Medical Advisory Boards 113
7.1.5 Jan 13, 2017: Fresenius Medical Care Announces Leadership Change in North America 113
7.1.6 Jan 13, 2017: Eppendorf: William Linton is new member of the Supervisory Board 114
7.2 Financial Announcements 114
7.2.1 Sep 01, 2017: Start of MRX-4TZT Phase I a' Clinical Trial in the United States 114
7.2.2 Aug 16, 2017: Curetis Announces Financial Results for the First Six Months of 2017 115
7.2.3 Aug 02, 2017: Eckert & Ziegler: Quarterly Report II 118
7.2.4 Aug 01, 2017: Fresenius confirms its guidance after a strong second quarter with double-digit sales and earnings growth 119
7.2.5 Jul 18, 2017: ECG-Guard Helps Users to Take Control of Their Health Through an Intuitive Mobile App 121
7.2.6 Jul 06, 2017: Epigenomics issues change in guidance for financial year 2017 122
7.2.7 Jun 29, 2017: Angel Catheter Pivotal Study Published in Journal of Vascular and Interventional Radiology 122
7.2.8 May 24, 2017: Curetis Provides Business and Financial Update for the First Quarter 2017 125
7.2.9 May 10, 2017: Epigenomics announces 2017 First Quarter Financial Results 126
7.2.10 Apr 26, 2017: Epigenomics Reports Results for Financial Year 2016 127
7.2.11 Apr 12, 2017: Curetis Reports Full-Year 2016 Financial Results and Updates 2017 Guidance 128
7.2.12 Nov 18, 2016: Curetis Publishes Business and Financial Update for the First Nine Months 2016 129
7.2.13 Nov 09, 2016: Epigenomics Announces 2016 Third Quarter and Nine Months Financial Results and Reports on Operational Highlights 131
7.2.14 Nov 03, 2016: Eckert & Ziegler Q3/2016: Rise in Radiopharma Segment Income keeps the Group on track, Positive outlook for 2017 132
7.3 Legal And Regulatory 132
7.3.1 Jan 31, 2017: Fresenius Medical Care reaches agreement on outstanding payments 132
7.4 Other Significant Developments 133
7.4.1 Jul 12, 2017: Fresenius Medical Care successfully amends and extends its credit agreement, ahead of schedule 133
7.4.2 Apr 28, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations 133
7.4.3 Feb 01, 2017: Streck signs distribution agreement with HiSS Diagnostics 133
7.5 Strategy And Business Planning 134
7.5.1 Sep 29, 2017: Fresenius lays cornerstone for new building at headquarters in Bad Homburg 134
7.5.2 Jun 08, 2017: Fresenius Medical Care sees excellent prospects for further growth and launches a new Global Efficiency Program at its Capital Markets Day 2017 134
7.5.3 Apr 06, 2017: Curetis Starts Subsidiary Ares Genetics to Advance Genetic Antibiotic Resistance Testing 135
7.5.4 Dec 08, 2016: numares Opens Singapore Subsidiary to Expand Its Diagnostic System into Asia 136
7.5.5 Nov 22, 2016: HELIOS lays foundation stone for new hospital building in Wiesbaden 137
8 Appendix 138
8.1 Research Methodology 139
8.1.1 Coverage 139
8.1.2 Secondary Research 139
8.1.3 Primary Research 140
8.1.4 Market Modeling and Forecasting 141
8.1.5 Company Share Analysis 142
8.1.6 Distribution Share Analysis 143
8.1.7 Benchmarking 143
8.2 GlobalData Consulting 143
8.3 Contact Us 144
8.4 Disclaimer 144

1.1 List of Tables
Table 1: Immuno Chemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 14
Table 2: Immuno Chemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 16
Table 3: Complement Deficiency Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 18
Table 4: Diabetes Assays Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 20
Table 5: Disease Specific Immunochemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 22
Table 6: Endocrinology Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 24
Table 7: IgE Allergy Blood Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 26
Table 8: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 28
Table 9: Immunochemistry Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 30
Table 10: Vitamins Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 32
Table 11: Complement Deficiency Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 34
Table 12: Diabetes Assays Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 36
Table 13: Disease Specific Immunochemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 38
Table 14: Endocrinology Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 40
Table 15: IgE Allergy Blood Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 42
Table 16: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 44
Table 17: Immunochemistry Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 46
Table 18: Vitamins Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 48
Table 19: Immuno Chemistry Market, Germany, Volume (Units), Historic, 2010-2017 50
Table 20: Immuno Chemistry Market, Germany, Volume (Units), Forecast, 2017-2024 52
Table 21: Complement Deficiency Tests Market, Germany, Volume (Units), Historic, 2010-2017 54
Table 22: Diabetes Assays Market, Germany, Volume (Units), Historic, 2010-2017 56
Table 23: Disease Specific Immunochemistry Market, Germany, Volume (Units), Historic, 2010-2017 58
Table 24: Endocrinology Tests Market, Germany, Volume (Units), Historic, 2010-2017 60
Table 25: IgE Allergy Blood Tests Market, Germany, Volume (Units), Historic, 2010-2017 62
Table 26: Immunochemistry Analyzers Market, Germany, Volume (Units), Historic, 2010-2017 64
Table 27: Immunochemistry Rapid Tests & POC Market, Germany, Volume (Units), Historic, 2010-2017 66
Table 28: Vitamins Tests Market, Germany, Volume (Units), Historic, 2010-2017 68
Table 29: Complement Deficiency Tests Market, Germany, Volume (Units), Forecast, 2017-2024 70
Table 30: Diabetes Assays Market, Germany, Volume (Units), Forecast, 2017-2024 72
Table 31: Disease Specific Immunochemistry Market, Germany, Volume (Units), Forecast, 2017-2024 74
Table 32: Endocrinology Tests Market, Germany, Volume (Units), Forecast, 2017-2024 76
Table 33: IgE Allergy Blood Tests Market, Germany, Volume (Units), Forecast, 2017-2024 78
Table 34: Immunochemistry Analyzers Market, Germany, Volume (Units), Forecast, 2017-2024 80
Table 35: Immunochemistry Rapid Tests & POC Market, Germany, Volume (Units), Forecast, 2017-2024 82
Table 36: Vitamins Tests Market, Germany, Volume (Units), Forecast, 2017-2024 84
Table 37: Immuno Chemistry Market, Germany, Average Price ($) Historic, 2010-2017 85
Table 38: Immuno Chemistry Market, Germany, Average Price ($), Forecast, 2017-2024 87
Table 39: Immuno Chemistry Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2017 89
Table 40: Immuno Chemistry Market, Germany, Company Share by Revenue ($m), USD Constant, 2017 91
Table 41: Immuno Chemistry Market Pipeline Products 95
Table 42: DIAsource ImmunoAssays Acquires Viro-Immun Diagnostics 98
Table 43: Cathay Fortune International to Acquire Epigenomics 99
Table 44: DiaSorin to Acquire ELISA Immunodiagnostic Business Portfolio from Siemens Healthcare for USD55.3 Million 101
Table 45: Epigenomics Raises USD8.5 Million in Private Placement of Bonds 103
Table 46: Fresenius Raises USD742.5 Million in Private Placement of 0.875% Notes Due 2022 104
Table 47: Fresenius Raises USD742.5 Million in Private Placement of 1.5% Notes Due 2024 105
Table 48: Fresenius Raises USD742.5 Million in Private Placement of 2.125% Notes Due 2027 106
Table 49: Fresenius Raises USD530.4 Million in Private Placement of 3% Notes Due 2032 107
Table 50: Epigenomics Raises USD6.5 Million in Private Placement of Shares 108
Table 51: Siemens Healthcare May Raise up to USD47.3 Billion in IPO 109
Table 52: Siemens Healthcare Plans IPO of Shares 110
Table 53: Singulex Enters into Agreement with Qiagen 111
Table 54: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 141

1.2 List of Figures
Figure 1: Immuno Chemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 13
Figure 2: Immuno Chemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 15
Figure 3: Complement Deficiency Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 17
Figure 4: Diabetes Assays Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 19
Figure 5: Disease Specific Immunochemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 21
Figure 6: Endocrinology Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 23
Figure 7: IgE Allergy Blood Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 25
Figure 8: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 27
Figure 9: Immunochemistry Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 29
Figure 10: Vitamins Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 31
Figure 11: Complement Deficiency Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 33
Figure 12: Diabetes Assays Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 35
Figure 13: Disease Specific Immunochemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 37
Figure 14: Endocrinology Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 39
Figure 15: IgE Allergy Blood Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 41
Figure 16: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 43
Figure 17: Immunochemistry Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 45
Figure 18: Vitamins Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 47
Figure 19: Immuno Chemistry Market, Germany, Volume (Units), Historic, 2010-2017 49
Figure 20: Immuno Chemistry Market, Germany, Volume (Units), Forecast, 2017-2024 51
Figure 21: Complement Deficiency Tests Market, Germany, Volume (Units), Historic, 2010-2017 53
Figure 22: Diabetes Assays Market, Germany, Volume (Units), Historic, 2010-2017 55
Figure 23: Disease Specific Immunochemistry Market, Germany, Volume (Units), Historic, 2010-2017 57
Figure 24: Endocrinology Tests Market, Germany, Volume (Units), Historic, 2010-2017 59
Figure 25: IgE Allergy Blood Tests Market, Germany, Volume (Units), Historic, 2010-2017 61
Figure 26: Immunochemistry Analyzers Market, Germany, Volume (Units), Historic, 2010-2017 63
Figure 27: Immunochemistry Rapid Tests & POC Market, Germany, Volume (Units), Historic, 2010-2017 65
Figure 28: Vitamins Tests Market, Germany, Volume (Units), Historic, 2010-2017 67
Figure 29: Complement Deficiency Tests Market, Germany, Volume (Units), Forecast, 2017-2024 69
Figure 30: Diabetes Assays Market, Germany, Volume (Units), Forecast, 2017-2024 71
Figure 31: Disease Specific Immunochemistry Market, Germany, Volume (Units), Forecast, 2017-2024 73
Figure 32: Endocrinology Tests Market, Germany, Volume (Units), Forecast, 2017-2024 75
Figure 33: IgE Allergy Blood Tests Market, Germany, Volume (Units), Forecast, 2017-2024 77
Figure 34: Immunochemistry Analyzers Market, Germany, Volume (Units), Forecast, 2017-2024 79
Figure 35: Immunochemistry Rapid Tests & POC Market, Germany, Volume (Units), Forecast, 2017-2024 81
Figure 36: Vitamins Tests Market, Germany, Volume (Units), Forecast, 2017-2024 83
Figure 37: Immuno Chemistry Market, Germany, Company Share (%) 2017 90

Filed in: In Vitro Diagnostic, Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......	$4950
Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact) Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......	$7500
Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......	$7500
Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028 Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......	$10995
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......	$7500
Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......	$7500
EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......	$7500
Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......	$7500
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model "Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......	$7500
Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Prenatal Screening is now routinely used in developed countries for early detection of fetal abnormalities. Various biochemical analytes are measured during the first or second trimester including free-beta human chorionic gonadotropin (hCG), total hCG, pregnancy associated plasma protein-A (PAPP-A), Alpha-fetoprotein (AFP), unconjugated estriol (uE3), and Inhibin A. These markers are used to screen for Down syndrome (Trisomy 21) as well as Edwards syndrome (Trisomy 18) and ectopic pregnancy. Additionally, maternal s......	$7500

Germany Immuno Chemistry Market Outlook to 2024

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026

Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model